Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-term atorvastatin before prostate surgery (pilot)
2011-005438-20Phase 2Completed
- Sponsor
- Tampere University
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of atorvastatin in prostate cancer (PCa), sponsored by Tampere University. Primary endpoints: Intratumoral cell cycle activity reduction, Increase in apoptosis and 1 more. Started May 2012; status: completed.
02
Drugs
atorvastatin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2011-005438-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005438-20.